These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6860550)

  • 1. Response to X-radiation and cytotoxic drugs of clonal subpopulations of different ploidy and metastatic potential isolated from RIF-1 mouse sarcoma.
    Reeve JG; Wright KA; Twentyman PR
    Br J Cancer; 1983 Jun; 47(6):841-8. PubMed ID: 6860550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of cross-sensitivity in the responses of clonal subpopulations isolated from the RIF-1 mouse sarcoma to selected nitrosoureas and nitrogen mustards.
    Reeve JG; Wright KA; Workman P
    Br J Cancer; 1984 Aug; 50(2):153-8. PubMed ID: 6466534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ploidy distribution of tumour cells derived from induced and spontaneously arising metastases of a murine radiation-induced sarcoma, RIF-1.
    Reeve JG; Twentyman PR
    Eur J Cancer Clin Oncol; 1982 Oct; 18(10):1001-6. PubMed ID: 6891636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response of tumour cells to radiation and cytotoxic drugs--a comparison of clonogenic and isotope uptake assays.
    Twentyman PR; Walls GA; Wright KA
    Br J Cancer; 1984 Nov; 50(5):625-31. PubMed ID: 6093839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
    Twentyman P; Workman P
    Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only.
    Honess DJ; Bleehen NM
    Br J Radiol; 1985 Jan; 58(685):63-72. PubMed ID: 4063642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal variation in the arrest, survival and growth of RIF-1 mouse sarcoma cells in the lungs of C3H mice.
    Reeve JG; Twentyman PR
    Br J Cancer; 1983 Jun; 47(6):833-40. PubMed ID: 6860549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids.
    Kwok TT; Twentyman PR
    Int J Cancer; 1985 May; 35(5):675-82. PubMed ID: 3997287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of radiosensitizer pretreatment on the response of the RIF-1 mouse sarcoma to cytotoxic drugs.
    Twentyman PR; Workman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):611-3. PubMed ID: 7107382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro response to hyperthermia or X-irradiation of diploid and tetraploid RIF-1 cells separated by centrifugal elutriation.
    Rowley R; Joyner DE; Stewart JR
    Int J Hyperthermia; 1987; 3(3):235-44. PubMed ID: 3655437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
    Siemann DW
    Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
    Siemann DW
    Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization by lipophilic nitroimidazoles.
    Twentyman PR; Workman P
    Br J Cancer; 1983 Jul; 48(1):17-26. PubMed ID: 6871076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemosensitization of CCNU in KHT murine tumor cells in vivo and in vitro by the agent RB 6145 and its isomer PD 144872.
    Siemann DW
    Radiother Oncol; 1995 Jan; 34(1):47-53. PubMed ID: 7792398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new mouse tumor model system (RIF-1) for comparison of end-point studies.
    Twentyman PR; Brown JM; Gray JW; Franko AJ; Scoles MA; Kallman RF
    J Natl Cancer Inst; 1980 Mar; 64(3):595-604. PubMed ID: 6928244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of various antineoplastic agents on an established human melanoma cell line (G-361).
    García Reverte JM; Bernabeu Esclapez A; Muñoz Ramos J; Vicente Ortega V; Canteras Jordana M
    Histol Histopathol; 1995 Jan; 10(1):79-84. PubMed ID: 7756747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.
    Welch DR; Nicolson GL
    Clin Exp Metastasis; 1983; 1(4):317-25. PubMed ID: 6242707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification by WR 2721 of the response to chemotherapy of tumours and normal tissues in the mouse.
    Twentyman PR
    Br J Cancer; 1983 Jan; 47(1):57-63. PubMed ID: 6295428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
    Siemann DW
    Br J Cancer; 1990 Sep; 62(3):348-53. PubMed ID: 2206941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.